Cardiology

DR. PETER YAN

Co-Founder, Medical Director

MBBS (Singapore), M. Med (Internal Medicine), FAMS (Cardiology)

Consultant Cardiologist and Physician, Specialist in Cardiology

Dr. Peter Yan is currently a Consultant Cardiologist and Physician in private practice at Gleneagles and Mt. Elizabeth Hospitals and was an Associate Professor in Medicine, Department of Medicine, National University of Singapore and a Senior Consultant Cardiologist, Cardiac Department of the National University Hospital, Singapore. He is a member of the American Heart Association (Clinical Cardiology, Cardiopulmonary Critical Care and Epidemiology). Dr. Yan sits on numerous International Advisory Boards on lipids, hypertension, anti-platelet and anti-coagulation therapy, coronary interventional devices and innovations. He was formerly the Medical Director of Parkway Heart and Vascular Centre and is currently a member of the Medical Advisory Board of Gleneagles Hospital and the Chair of the Gleneagles Cardiology Specialist Interest Group.

Holding numerous positions in established Heart Associations and  various Cardiology Boards, Dr. Yan was the first to introduce Coronary Angioplasty (in 1986) and the Coronary Stent Program (1987) to the National University Hospital, Cardiac Department. He was one of the pioneering members of the First Singapore Mass CPR Training.

Dr. Yan has published and presented numerous papers in renown international and local journals. He has been invited to lecture extensively internationally and in the Asia-Pacific region. He had previously been a member of the Editorial Board of the ASEAN Heart Journal, the Singapore Medical Journal and was co-editor of the publication, “Coronary Artery Disease: The Singapore Perspective” and Editor-in-Chief of the Course Book for the 11^th Live Demonstration Course in Cardiovascular Intervention, 2002.

Dr. Yan’s current research interests include, the evaluation of new drug-eluting stents, new device treatment of high blood pressure, lipid intervention and assessment of the vulnerability of the atheromatous plaques. He also has a special interest in lifestyle modifications and interventions, and the development and implementation of “precision medicine” focusing on personalised cardiovascular medicine (genomic-driven cardiovascular therapies).